Quest Diagnostics…
USUSDQuest Diagnostics Incorporated (LSE:0KSX) — Medical Specialities. Numărul de burse pe care se tranzacționează acțiunile companiei: 2. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.
Despre companie
- Site web
- questdiagnostics.com
- Relații cu investitorii
- ir.questdiagnostics.com/overview/default.aspx
- Sector
- Health Care · Medical Specialities
- Sediu central
- Madison, United States
- Director general
- Steve Rusckowski
- Angajați
- 46 000
- Fondată
- 1967
- Listată din
- 29.01.2018 (LSE:0KSX)
- Acțiuni în circulație
- 110.37 mil. la 2026-07-15
- Free float
- 109.81 mil.
- Capitalizare de piață
- 25.21 mld. USD
- Insideri
- 0.43%
- Investitori instituționali
- 98.9%
- Industrie (SIC)
- Services-Medical Laboratories
- LEI
- 8MCWUBXQ0WE04KMXBX50
- Rata de distribuire
- 34.2%
- FCF
- 1.35 mld. USD27%
- Datorie
- 6.38 mld. USD3.7 ani FCF
- Vechimea dividendelor
- 22 ani
- Câștiguri, FCF și dividende plătite — pentru cele 12 luni până la 30.06.2026 (cel mai recent raport al companiei).
Descriere
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Dividende
Quest Diagnostics Incorporated (DGX) plătește dividende trimestrial. În ultimele 12 luni, s-au plătit 3.38 USD pe acțiune (plăți: 4). Aceasta reprezintă aproximativ 1.46% din prețul actual al acțiunilor. Pe baza istoricului plăților, următoarea dată ex-dividend este așteptată în jurul datei de 05.01.2027. Istoric neîntrerupt al dividendelor: 22 ani.
| Data ex | Plată | Sumă | % | Tip | Simbol |
|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-21 | 0.8600 USD | 0.4/1.5 % | trimestrial | US:DGX |
| 2026-07-08 | 2026-07-22 | 0.8600 USD | 0.4/1.4 % | trimestrial | US:DGX |
| 2026-04-06 | 2026-04-20 | 0.8600 USD | 0.4/1.4 % | trimestrial | US:DGX |
| 2026-01-13 | 2026-01-28 | 0.8000 USD | 0.3/1.4 % | trimestrial | US:DGX |
| 2025-10-03 | 2025-10-20 | 0.8000 USD | 0.3/≈1.4 % | trimestrial | US:DGX |
| 2025-07-07 | 2025-07-21 | 0.8000 USD | 0.3/≈1.4 % | trimestrial | US:DGX |
| 2025-04-07 | 2025-04-21 | 0.8000 USD | 0.3/≈1.4 % | trimestrial | US:DGX |
Știri din această săptămână
Încă nu există știri de pe site-ul companiei.
Cei mai mari acționari
| Deținător | Participație | Acțiuni | Data raportului |
|---|---|---|---|
| Blackrock Inc. | 8.4% | 9.28 mil. | 2026-06-30 |
| Vanguard Capital Managem… | 6.55% | 7.23 mil. | 2026-06-30 |
| Vanguard Portfolio Manag… | 5.55% | 6.13 mil. | 2026-06-30 |
| State Street Corporation | 5% | 5.52 mil. | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.93% | 5.44 mil. | 2026-06-30 |
| Boston Partners | 4.3% | 4.74 mil. | 2026-06-30 |
| JPMORGAN CHASE & CO | 3.19% | 3.52 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.51 mil. | 2026-06-30 |
| Geode Capital Management… | 2.84% | 3.14 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.6% | 2.87 mil. | 2026-06-30 |
| Morgan Stanley | 2.23% | 2.46 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.17% | 2.4 mil. | 2026-06-30 |
| Edgepoint Investment Gro… | 2.04% | 2.25 mil. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.33% | 1.47 mil. | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 1.43 mil. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 1.36 mil. | 2026-08-31 |
| John Hancock Funds III-D… | 1.09% | 1.2 mil. | 2026-07-31 |
| JPMorgan Trust II-JPMorg… | 1.04% | 1.15 mil. | 2026-06-30 |
| T. Rowe Price Dividend G… | 1% | 1.11 mil. | 2026-06-30 |
| John Hancock Funds III-D… | 0.96% | 1.06 mil. | 2026-07-31 |
| DAVIS J E CAUSEY (Chief… | ≈0.13% | 142 423 | 2026-03-04 |
| DAVIS JAMES E (Chief Exe… | ≈0.11% | 122 423 | 2026-09-01 |
| DOHERTY CATHERINE T (Off… | ≈0.06% | 71 624 | 2026-03-05 |
| PREVOZNIK MICHAEL E (Gen… | ≈0.04% | 42 337 | 2026-08-28 |
| DEPPE MICHAEL J (Officer… | ≈0.03% | 35 196 | 2026-03-04 |
| SAMAD SAMER ABDUL (Chief… | ≈0.03% | 33 478 | 2026-07-22 |
| RING TIMOTHY M (Director… | ≈0.03% | 31 140 | 2026-05-20 |
| PFEIFFER GARY M (Directo… | ≈0.03% | 31 005 | 2026-05-20 |
| MAIN TIMOTHY L (Director… | ≈0.02% | 27 460 | 2026-07-22 |
| GREGG VICKY B (Director) | ≈0.02% | 18 386 | 2026-07-22 |